Matches in DBpedia 2015-10 for { ?s ?p "Enrico Fazzini, D.O., Ph.D. is a neurologist and an osteopathic physician. He is considered an expert on Parkinson's disease and has published numerous research publications on the subject. He has been involved in a number of clinical trials for new pharmaceutical treatments for Parkinson's disease. He attended the University of Osteopathic Medicine and Health Sciences in Des Moines, Iowa. He is board certified in neurology by both the M.D. and D.O. medical boards and is a Fellow of the American College of Neuropsychiatrists. He is currently a clinical associate professor at the New York University School of Medicine and the New York Institute of Technology College of Osteopathic Medicine and Director of the American Parkinson's Disease Association New York Center at the New York Institute of Technology College of Osteopathic Medicine. Dr. Enrico Fazzini completed his neurology training at Boston University in 1987 and his fellowship in Movement Disorders at Columbia Presbyterian in 1989 where he was instrumental in the development of botulinum toxin type A for use in dystonia. In addition to being a neurologist, Dr. Fazzini has a Ph.D. in Behavioral Neuroscience from Boston University and is an expert on the diagnosis and treatment of patients with traumatic brain injuries."@en }
Showing triples 1 to 1 of
1
with 100 triples per page.
- Enrico_Fazzini abstract "Enrico Fazzini, D.O., Ph.D. is a neurologist and an osteopathic physician. He is considered an expert on Parkinson's disease and has published numerous research publications on the subject. He has been involved in a number of clinical trials for new pharmaceutical treatments for Parkinson's disease. He attended the University of Osteopathic Medicine and Health Sciences in Des Moines, Iowa. He is board certified in neurology by both the M.D. and D.O. medical boards and is a Fellow of the American College of Neuropsychiatrists. He is currently a clinical associate professor at the New York University School of Medicine and the New York Institute of Technology College of Osteopathic Medicine and Director of the American Parkinson's Disease Association New York Center at the New York Institute of Technology College of Osteopathic Medicine. Dr. Enrico Fazzini completed his neurology training at Boston University in 1987 and his fellowship in Movement Disorders at Columbia Presbyterian in 1989 where he was instrumental in the development of botulinum toxin type A for use in dystonia. In addition to being a neurologist, Dr. Fazzini has a Ph.D. in Behavioral Neuroscience from Boston University and is an expert on the diagnosis and treatment of patients with traumatic brain injuries.".